Unitedhealth Group (UNH)


UnitedHealth Group Incorporated is a healthcare company listed on the NYSE under the ticker UNH. Through its four operating segments—Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare—the company provides a broad range of healthcare-related products and services in the United States and international markets. Its activities include care delivery and care management, wellness and consumer engagement, health financial services, software and advisory services, managed services outsourcing, and pharmacy care programs. UnitedHealthcare also offers health benefit plans and related services for employers, individuals, and public-sector programs, including Medicaid and other state and federal health coverage initiatives. Founded in 1974, UnitedHealth Group is based in Eden Prairie, Minnesota.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-UNH
$503.10
16.3% Upside
Fair
$475.23
9.8% Upside
Fair
Good
9.28
2.2%
October 9, 2026
27.8x
3.8x
0.9x
382.8 B
380.9 B
16.0%
99.7%
2.7
57.3%
167.2%
Valuation • Fair Value

Unitedhealth Group (NYSE-UNH) Fair Value by Valuation Model

Compare the primary fair value estimate for Unitedhealth Group (NYSE-UNH) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$503.10

Estimated upside of 16.3% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

NM

Discounted cash flow valuation reference.

Ben Graham Formula Value

$172.54

Classic Ben Graham valuation formula reference.

DDM Fair Value

$572.82

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$456.62

Comparable-company valuation reference.

Analyst Price Target

$475.23

Analysts imply upside of 9.8%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Unitedhealth Group (NYSE-UNH) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Unitedhealth Group (NYSE-UNH)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

450.1 B

Current operating scale indicator.

Revenue Forecast

445.4 B

Forward revenue estimate.

EBITDA

24.261 B

Current operating profitability reference.

EBITDA Forecast

29.367 B

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Unitedhealth Group (NYSE-UNH) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Unitedhealth Group (NYSE-UNH)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Good

Positive financial-health read.

Piotroski Score

6

Mid-range quality score.

Beneish M-Score

-2.79

No elevated caution signal from this screen.

Altman Z-Score

2.7

Intermediate risk zone.

FCF / Net Income

167.2%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Unitedhealth Group (NYSE-UNH). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Unitedhealth Group (NYSE-UNH)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

October 9, 2026

Days to Earnings

80

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

2.2%

Income yield reference.

Upcoming Dividend

9.28

Upcoming distribution amount.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

USD

Currency used for the distribution.

Payout Ratio

57.3%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Unitedhealth Group (NYSE-UNH), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Unitedhealth Group (NYSE-UNH) Stock Forecast & Technical Outlook

Review Unitedhealth Group (NYSE-UNH) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Unitedhealth Group (NYSE-UNH) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Unitedhealth Group (NYSE-UNH) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Unitedhealth Group (NYSE-UNH) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Unitedhealth Group (NYSE-UNH) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Unitedhealth Group (NYSE-UNH) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Unitedhealth Group (NYSE-UNH)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Unitedhealth Group (NYSE-UNH) has a Strong Buy consensus, with 16 buy, 5 hold and 0 sell recommendations in the current data set.

Buy 16
Hold 5
Sell 0
FAQ Fast Investor Answers

Unitedhealth Group (NYSE-UNH) Stock FAQ

Quick answers about Unitedhealth Group (NYSE-UNH) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$503.10
Estimated upside 16.3%
Valuation Rating
Undervalued
Estimated upside of 16.3%
Analyst Target
$475.23
Implied upside 9.8%
Financial Health
Good
Current financial-health read

The current fair value estimate for Unitedhealth Group (NYSE-UNH) is $503.10. This implies an estimated upside of 16.3% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 16.3% versus the current market price.

The available analyst price target for Unitedhealth Group (NYSE-UNH) is $475.23. The analyst target implies estimated upside of 9.8%.

The current financial health read for Unitedhealth Group (NYSE-UNH) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Unitedhealth Group (NYSE-UNH) is October 9, 2026.

Based on the current data, dividend yield is 2.2%, upcoming dividend amount is 9.28.

The current P/E ratio listed for Unitedhealth Group (NYSE-UNH) is 27.8x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Unitedhealth Group is 382.8 B.

The current enterprise value listed for Unitedhealth Group is 380.9 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Unitedhealth Group is NYSE-UNH, and the stock is listed on NYSE.

Unitedhealth Group (NYSE-UNH) is listed on NYSE.

The current debt-to-total-capital ratio listed for Unitedhealth Group is 16.0%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Unitedhealth Group is 99.7%. Free float helps investors understand how much of the share base is available for public trading.